Top Tweets for #JCOG1007

over 2 years ago

Fantastic data! Here's additional information on this topic: 📌#JCOG1007: 1-3 unresectable mets. Upfront surgery. FOLFOX6 or CapeOX-Bev. Trend to 📉PFS/OS. 📌60d mortality 11% on #CAIRO4. 📌Should regular endoscopic surveillance guide potential role of deferred primary tumor surgery? #PRIMETX #CRCSM

Jeff Ryckman

@jryckman3

over 2 years ago

Discussion: #CRCSM 📌 Two additional trials (SYNCHRONOUS, CCRe-IV) demonstrate trend to 📉 OS with upfront primary tumor resection (PTR). 📌 Roughly 1/4 were unable to receive vital systemic therapy known to improve OS in the upfront PTR arms. https://t.co/VJ5pZQQszj

jryckman3's tweet photo. Discussion: #CRCSM

📌 Two additional trials (SYNCHRONOUS, CCRe-IV) demonstrate trend to 📉 OS with upfront primary tumor resection (PTR).
📌 Roughly 1/4 were unable to receive vital systemic therapy known to improve OS in the upfront PTR arms.

https://t.co/VJ5pZQQszj https://t.co/78iYaDoeSJ

Jeff Ryckman

@jryckman3

about 4 years ago

Discussion: #CRCSM 📌#JCOG1007: 1-3 unresectable mets. Upfront surgery. FOLFOX6 or CapeOX-Bev. 📌Trend to 📉 PFS/OS. 📌60d mortality 11% on #CAIRO4. 📌Should regular endoscopic surveillance guide potential role of deferred primary tumor surgery? https://t.co/i7iTEUmOnZ 14/

Top Tweets for #JCOG1007

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users